Investors Asset Management of Georgia’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Investors Asset Management of Georgia’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-333	Closed	-$3.91K	–	177
2022 Q4	$3.91K	Hold	333	–	–	﹤0.01%	169
2022 Q3	$7K	Hold	333	–	–	﹤0.01%	514
2022 Q2	$8K	Buy	+333	New	+$11.3K	﹤0.01%	442

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Investors Asset Management of Georgia's VBIV Position: Q1 2023 in Review

Investors Asset Management of Georgia sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2023, closing a stake of 333 shares — an estimated $3.91K sold.

Investors Asset Management of Georgia first reported a position in VBIV in Q2 2022 and held it in 3 quarters. The position peaked at $8K in Q2 2022. 95 funds tracked by Wall St. Rank hold VBIV as of Q1 2023.

Investors Asset Management of Georgia reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2023 after selling out during the quarter.
Investors Asset Management of Georgia sold 333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2023, an estimated $3.91K.
Investors Asset Management of Georgia first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2022 and held it in 3 quarters.
Investors Asset Management of Georgia's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $8K in Q2 2022.
95 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2023.

Based on Investors Asset Management of Georgia's 13F filing for Q1 2023, filed 1 May 2023.